Skip to main content
SpringerLink
Log in

Treating Obesity in the Physician’s Office

  • Chapter
The Management of Eating Disorders and Obesity

Part of the book series: Nutrition ◊ and ◊ Health ((NH))

  • 204 Accesses

Abstract

Disordered eating is among the most common behaviors with clinical consequence seen in developed countries. In addition, the prevalence of the established eating disorders (i.e., bulimia nervosa and anorexia nervosa) and obesity is increasing. The factors which may contribute to the increase in vulnerability to disordered eating and thus contribute to this increase in prevalence include improvements in food availability, increasing societal pressure toward restrained eating and fat avoidance, and individual genetic susceptibility. One additional feature the eating disorders have in common is multimodal therapy (Table 1). The initial steps in this therapy are thorough medical and dietary assessments, often coupled with behavioral psychotherapy or other behavioral intervention. When this is insufficient, pharmacologic therapy, often with serotonergic agents, may also be employed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rett K, Wiclmayr M, Mehnert H. What is the clinical significance of insulin resistance. J Cardiovasc Pharmacol 1992; 20: S22 - S26.

    Article  Google Scholar 

  2. Wilson TW, Grim CE. Biohistory of slavery and blood pressure differences in blacks today. A hypothesis. Hypertension 1991; 17: I122–1128.

    Article  CAS  Google Scholar 

  3. Blaustein MP, Grim CE. The pathogenesis of hypertension: black-white differences. Cardiovasc Clin 1991; 21: 97–114.

    CAS  Google Scholar 

  4. Weder AB, Schork NJ. Adaptation, allometry, and hypertension. Hypertension. 1994; 24: 145–156.

    Article  CAS  Google Scholar 

  5. Turner RC, Levy JC, Clark A. Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms. Q J Med 1993; 86: 413–417.

    CAS  Google Scholar 

  6. Wendorf M. Archaeology and the “thrifty” non insulin dependent diabetes mellitus (NIDDM) genotype. Adv Perit Dial 1992; 8: 201–207.

    CAS  Google Scholar 

  7. Brown G, Nesse R.Evolutionary Concepts in Medicine.

    Google Scholar 

  8. Garner DM, Garfinkel PE, Schwartz D, Thompson M. Cultural expectations of thinness in women. Psychological Reports 1980; 47: 483–491.

    Article  CAS  Google Scholar 

  9. Hetherington MM, Rolls BJ. Eating behavior in eating disorders: response to preloads. Physiol Behav 1991; 50: 101–108.

    Article  CAS  Google Scholar 

  10. Zerbe KJ. Anorexia nervosa and bulimia nervosa. When the pursuit of bodily “perfection” becomes a killer. Postgrad Med 1996; 99: 167–169.

    Google Scholar 

  11. Rolls BJ, Andersen AE, Moran TH, McNelis AL, Baler HC, Fedoroff IC. Food intake, hunger and satiety after preloads in women with eating disorders. Am J Clin Nutr 1992; 55: 1093–1103.

    CAS  Google Scholar 

  12. Rock CL, V asantharaj an S. Vitamin status of eating disorder patients: relationship to clinical indices and effect of treatment. Int J Eat Disord 1995; 18: 257–262.

    Article  CAS  Google Scholar 

  13. Kreipe RE. Eating disorders among children and adolescents. Pediatr Rev 1995; 16: 370–379.

    Article  CAS  Google Scholar 

  14. Jimerson DC, Lesem MD, Kaye WH, Hegg AP, Brewerton TD. Eating disorders and depression: is there a serotonin connection? Bio Psychiatry 1990; 28: 443–454.

    Article  CAS  Google Scholar 

  15. Leibowitz SF. The role of serotonin in eating disorders. Drugs 1990; 39: 33–48.

    Article  CAS  Google Scholar 

  16. Jimerson DC, Lesern MD, Hegg AP, Brewerton TD. Serotonin in human eating disorders. Ann N YAcad Sci 1990; 600: 532–544.

    Article  CAS  Google Scholar 

  17. Stern JS, Thomas PR. 1995. A commentary on weighing the options: criteria for evaluating weight-management programs. Obes Res 1995; 3(6): 589–590.

    Article  CAS  Google Scholar 

  18. Laine C, Davidoff F. 1996. Patient-Centered Medicine. JAMA 1996; 275(2): 152–156.

    Article  CAS  Google Scholar 

  19. Robinson BE, Bacon JG, O’Reilly J. 1993. Fat phobia: Measuring, understanding, and changing anti-fat attitudes. International Journal of Eating Disorders 14(4): 467–80.

    Article  CAS  Google Scholar 

  20. Rogers RS, Goldstein DJ. 1996. Obese Patient Perspective Questionnaire posted on the Internet.

    Google Scholar 

  21. Daly A. Diabesity: the deadly pentad disease. Diabetes Educator 1994; 20: 156–158, 160–162.

    Google Scholar 

  22. Straw WE. Obesity-a killer disease? J Fam Pract 1986; 22: 461, 462.

    Google Scholar 

  23. Gordon T, Kannel WB. Obesity and cardiovascular disease: the Framingham study. Clin Endo Metab 1976; 5: 367–375.

    Article  CAS  Google Scholar 

  24. Oboler SK, LaForce M. The periodic physical examination in asymptomatic adults. Ann Intern Med 1989; 110: 214–226.

    CAS  Google Scholar 

  25. Hayward RS, Steinberg EP, Ford D, Roizen MF, Roach KW. Preventive care guidelines: 1991. Ann Intern Med 1991; 114: 758–783.

    CAS  Google Scholar 

  26. Frame PS, Carlson SJ. A critical review of periodic health screening using specific criteria. Part 1: Selected diseases of the respiratory, cardiovascular, and central nervous systems. J Fam Pract 1975; 2: 29–36.

    CAS  Google Scholar 

  27. Hansen BC. Obesity, diabetes, and insulin resistance: implications from molecular biology, epidemiology, and experimental studies in humans and animals. Diabetes Care 1995; 18: A2 - A9.

    Article  CAS  Google Scholar 

  28. Frank A. Futility and avoidance: medical professionals in the treatment of obesity. JAMA 1993; 269: 2132–2133.

    Article  CAS  Google Scholar 

  29. Price JH, Desmond SM, Krol RA, Snyder FF, O’Connell JK Family practice physicians’ beliefs, attitudes, and practices regarding obesity. Am J Prey Med 1987; 3: 339–344.

    CAS  Google Scholar 

  30. Maiman LA, Wang VL, Becker MH, Finlay J, Simonson M. Attitudes toward obesity and the obesity among professionals. J Am Diet Assoc1979; 74: 331–336.

    Google Scholar 

  31. Cade J, O’Connell S. Management of weight problems and obesity: knowledge, attitudes and current practice of general practitioners. Brit J Gen Pract 1991; 41: 147–150.

    CAS  Google Scholar 

  32. Heath C, Grant W, Marcheni P, Kamps C. Do family physicians treat obesity? Farn Med 1993; 25: 401, 402.

    Google Scholar 

  33. Wooley SC, Wooley OW. Should obesity be treated at all? Psychol Ann 1983; 13: 884–888.

    Google Scholar 

  34. Stern JS, Thomas PR. A commentary on weighing the options: criteria for evaluating weight-management programs. Obes Res 1995; 3: 589, 590.

    Google Scholar 

  35. Perri MG, Sears SF, Clark JE. Strategies for improving weight loss: toward a continuous care model of obesity management. Diabetes Care 1993; 16: 200–209.

    Article  CAS  Google Scholar 

  36. Holmes MD, Zysow B, Delbanco TL. An analytic review of current therapies for obesity. J Fam Pract 1989; 28: 610–616.

    CAS  Google Scholar 

  37. Kolotkin RL, Head S, Hamilton M, Tse CJ. Assessing impact of weight on quality of life. Obes Res 1995; 3: 49–56.

    Article  CAS  Google Scholar 

  38. Rand SW, Macgregor MC. Successful weight loss following obesity surgery and the perceived liability of morbid obesity. Int J Obes 1991; 15: 577–579.

    CAS  Google Scholar 

  39. Coleman JA. Discrimination at large. Newsweek 1993; Aug 3: 9.

    Google Scholar 

  40. Prochalska JO. Strong and weak principles for progressing from preconteplation to action on the basis of twelve problem behaviors. Health Psychol 1994; 13: 47–51.

    Article  Google Scholar 

  41. Thomas PR, ed. Weighing the Options: Criteria for Evaluating Weight-Management Programs, vol. 1. National Academy Press, Washington D.C., 1995, 198–209.

    Google Scholar 

  42. Yanovksi S. Binge eating disorder, appendix A: questionnaire on eating and weight patterns-revised (QEWP-R). Obes Res 1993; 1: 319–322.

    Google Scholar 

  43. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12E: 1106–1110.

    Article  CAS  Google Scholar 

  44. Crapo L. Cushing’s syndrome: a review of diagnostic tests. Metab 1979; 28: 955–977.

    Article  CAS  Google Scholar 

  45. Matsuoka LY, Gavin JR, Kupchella CE, Dietrich JG. Acanthosis nigricans, hypothyroidism, and insulin resistance. Am J Med 1986; 81: 58–61.

    Article  CAS  Google Scholar 

  46. Logue E, Smucker WD, Bourguet CC, and the Nutrition, Exercise, and Obesity Reasearch Group. Identification of obesity: waistlines or weight? J Fam Pract 1995; 41: 357–363.

    CAS  Google Scholar 

  47. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. Br Med J 1995; 311: 158–161.

    Article  CAS  Google Scholar 

  48. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardio11994; 73: 460–468.

    Google Scholar 

  49. Sjostrom CD, Hakangard AC, Lissner L, Sjostrom L. Body compartment and subcutaneous adipose distribution-risk factor patterns in obese subjects. Obes Res 1995; 3: 9–22.

    Article  CAS  Google Scholar 

  50. Egger G. The case for using waist to hip ratio measurements in routine medical checks. Med J Aust 1992; 156: 280–285.

    CAS  Google Scholar 

  51. Irvine MJ. Is knowing your cholesterol harmful? J Clin Epidemiol 1994; 47: 131–145.

    Article  CAS  Google Scholar 

  52. Goldstein DJ. Beneficial effects of modest weight loss. Int J Obes 1992; 16: 397–415.

    CAS  Google Scholar 

  53. Amsterdam EA, Helfand M, Schnitzer TJ, Weir GC, Young CD. Following the patient with chronic stable disease. Patient Care 1995; 29: 22–42.

    Google Scholar 

  54. American Diabetes Association. Nutrition recommendations and principles for people with diabetes. Diabetes Care 1994; 17: 519–522.

    Google Scholar 

  55. Franz MJ, Horton ES, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, et al. Nutrition principles for the management of diabetes and related complications. Technical review. Diabetes Care 1994; 17: 490–518.

    CAS  Google Scholar 

  56. Garrow JS, Webster JD. Long-term results of treatment of severe obesity with jaw wiring and waist cord. Proc Nutr Soc 1986; 45: 199A.

    Google Scholar 

  57. Fernstrom MH. Drugs that cause weight gain. Obes Res 1995; 3(suppl 4): 435S - 439S.

    Article  CAS  Google Scholar 

  58. Goldstein DJ, Rampey AH, Roback PJ, Wilson M, Hamilton SH, Sayler, Tolefson GD. Efficacy and safety of long-term fluoxetine treatment of obesity-maximizing success. Obes Res 1995; 3(suppl 4): 481S - 490S.

    Article  CAS  Google Scholar 

  59. Dourish CT. Multiple serotonin receptors: opportunities for new treatments for obesity? Obes Res 1995; 3(suppl 4): 449S - 462S.

    Article  CAS  Google Scholar 

  60. Reaven GM, Lithell H, Landsberg. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N Eng J Med 1996; 334: 374–381.

    Article  CAS  Google Scholar 

  61. Editorial. Drugs causing weight gain. Br Med J 1974; 1: 168.

    Google Scholar 

  62. Marin P. Testosterone and regional fat distribution. Obes Res 1995; 3(Suppl 4): 6095–612S.

    Google Scholar 

  63. Schteingart DE. Effectiveness of phenylpropanolamine in the management of moderate obesity. Int J Obes 19992; 16: 487–493.

    Google Scholar 

  64. Shieh S-M, Sheu WH-H, Shen D-C, Fuh MM-T, Chen Y-DI, Reaven GM. Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension. Am J Hypertens 1992; 5: 827–831.

    CAS  Google Scholar 

  65. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610–630.

    Article  CAS  Google Scholar 

  66. Bailey CJ. Biguanides and NIDDM. Diabetes Care 1992; 15: 755–772.

    Article  CAS  Google Scholar 

  67. Coniff RF, Shapiro JA, Seaton TB, Hoogwerf BJ, Hunt JA. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes. Diabetes Care 1995; 18: 928–931.

    Article  CAS  Google Scholar 

  68. Henry RR, Gumbiner B. Benefits and limitations of very low calorie diet therapy in obese NIDDM. Diabetes Care 1991; 14: 802–823.

    Article  CAS  Google Scholar 

  69. Bistrian BR. Clinical use of a protein-sparing modified fast. JAMA 1978; 240: 2299–2301.

    Article  CAS  Google Scholar 

  70. Wadden TA, Stunkard AJ, Brownell KD. Very low calorie diets: their efficacy, safety, and future. Ann Intern Med 1983; 99: 675–684.

    CAS  Google Scholar 

  71. American Dietetic Association. Very-low-calorie weight loss diets. J Am Diet Assoc 1990; 90:722–726 (editorial).

    Google Scholar 

  72. Lichtman SW, Pisarka K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992; 327: 1893–1898.

    Article  CAS  Google Scholar 

  73. Stuart MR, Lieberman JA. Finding time for counseling in primary care. Patient Care 1994; 28: 118–129.

    Google Scholar 

  74. Depue JD, Clark MM, Ruggiero L, Medeiros ML, Pera V. Maintainance of weight loss: a needs assessment. Obes Res 1995; 3: 241–248.

    Article  CAS  Google Scholar 

  75. Perri MG, Nezu AM, Patti ET, McCann KL. Effect of length of treatment of weight loss. J Consult Psychol. 1989; 57: 450–452.

    Article  CAS  Google Scholar 

  76. Kayman S, Bruvold W, Stern JS. Maintainance and relapse after weight loss in women: behavioral aspects. Am J Clin Nutr 1990; 52: 800–807.

    CAS  Google Scholar 

  77. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WGH, Boyce V, Howard BV, Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988; 318: 467–472.

    Article  CAS  Google Scholar 

  78. Allred JB. Too much of a good thing? An overemphasis on eating low-fat foods may be contributing to the alarming increase in overweight among United States adults. J Am Diet Assoc 1995; 95: 417, 418.

    Google Scholar 

  79. Yanovski SZ. A practical approach to treatment of the obese patient. Arch Fam Med 1993; 2: 309–316.

    Article  CAS  Google Scholar 

  80. The Weight–Control Information Network, 1 Win Way, Bethesda, MD 20892–3665. Phone: 301–9511120; Fax: 301–951–1107; Internet: WINNIDK@aol.com

    Google Scholar 

  81. Bray GA. Use and abuse of appetite—suppressant drugs in the treatment of obesity. Ann Int Med 1993; 119: 707–713.

    CAS  Google Scholar 

  82. Weintraub MW. Long-term weight control: the National Heart, Lung, and Blood Institute-Funded Multimodal Intervention Study. Clin Pharmacol Ther 1992; 51: 581–585.

    Article  CAS  Google Scholar 

  83. Guidelines for the approval and use of drugs to treat obesity. A position paper of the North American Association for the Study of Obesity. Obes Res 1995; 3: 473–478.

    Article  Google Scholar 

  84. Atkinson RL, Blank RC, Loper JF, Schumacher D, Lutes RA. Obes Res 1995; 3(suppl 4): 497S - 500S.

    Article  CAS  Google Scholar 

  85. Mills K. Serotonin syndrome. Amer Fam Phys 1995; 52: 1475–1482.

    CAS  Google Scholar 

  86. Wolf AM, Colditz GA. The cost of obesity. Pharmacoeconomics 1994; 5(suppl 5): 34–37.

    Article  CAS  Google Scholar 

  87. Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, et al. Long-term weight control study. Clin Pharm Ther 1991; 51: 586–601.

    Google Scholar 

  88. Brownell MD, Wadden TA. Theheterogeneity of obesity: fitting treatments to individals. Behav Ther 1991; 22: 153.

    Article  Google Scholar 

  89. Smalley KJ, Knerr AK, Kendrick ZV, et al. Reassessment of body mass indices. Am J Clin Nutr 1990; 52: 405.

    CAS  Google Scholar 

  90. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. NEJM 1995; 333: 677–685.

    Article  CAS  Google Scholar 

  91. Bjorntorp P. Regional patterns of fat distribution. Ann Intern Med 1985; (Part II ): 994.

    Google Scholar 

  92. Young TK, Gelskey DE. Is noncentral obesity metabolically benign? JAMA 1995; 274: 1939–1941.

    Article  CAS  Google Scholar 

  93. Seim HC, Mitchell JE, Pomeroy C, de Zwaan M. Electeocardiographic findings with very low calorie dieting. Int J Obes 1995; 19: 817–819.

    CAS  Google Scholar 

  94. Brenot F, Herve P, et al. Primary pulmonary hypertension and fenfluramine use. Br Heart J 1993; 70: 537–541.

    Article  CAS  Google Scholar 

  95. Vanitallie, TB. Therapeutic weight-loss: a serious need for guiding principles grounded in physiology. In: Vanitallie TB, Simopoulos AP, eds. Obesity: New Directions in Assessment and Management. Charles Press, Philadelphia, 1995.

    Google Scholar 

  96. Kayman S, Bruvold W, Stern JS. Maintenance and relapse after weight-loss in women: behavioral aspects. Amer J Clin Nutr 1990; 52: 800–807.

    CAS  Google Scholar 

  97. Jakicic JM, Wing RR, Butler BA, Robertson RJ. Prescribing exercise in short bouts versus one continuous bout: effects on adherence, cardiorespiratory fitness and weight-loss in overweight women. Int J Obes 1995; 19: 893–901.

    CAS  Google Scholar 

  98. Spitz A, Heymsfield S, Blank RC. Drug therapy for obesity: clinical considerations. Endocrine Prac. 1995; 1: 274–279.

    Google Scholar 

  99. Goldstein, DJ. Beneficial health effects of modest weight-loss. Int J Obes. 1992; 16:397–415,.

    CAS  Google Scholar 

  100. Holman SL, Goldstein DJ, Enas GG. Pattern analysis method for assessing successful weight reduction. Int J.Obes 1994; 18: 281–285.

    CAS  Google Scholar 

  101. Goldstein DJ,Rampey AH Jr., Roback Pi, Wilson MG, Hamilton SH, Sayler ME, et al. Efficacy and safety of long-term fluoxetine treatment of obesity—maximizing success. Obes Res 1995; 3:481S–490S.

    Article  Google Scholar 

  102. Weintraub M, Sundaresan PR, Madan M, Schuster B, Balder A, Lasagna L, et al. Long-term weight control study. I (weeks 0 to 34): The enhancement of behavior modification, caloric restriction and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 1992; 51: 586–594.

    Article  CAS  Google Scholar 

  103. Roback PJ,Goldstein DJ, Rampey Jr AH, Wilson MG. Baseline predictors of success when comparing two treatments. Obes Res 1994; 2:337–347.

    Article  CAS  Google Scholar 

Download references

Authors
  1. David J. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald S. Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard A. Lutes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roy C. Blank
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lilly Research Laboratories, Indiana University School of Medicine, Indianapolis, IN, USA

    David J. Goldstein MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goldstein, D.J., Rogers, R.S., Lutes, R.A., Blank, R.C. (1999). Treating Obesity in the Physician’s Office. In: Goldstein, D.J. (eds) The Management of Eating Disorders and Obesity. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-694-2_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-694-2_20

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-6761-2

  • Online ISBN: 978-1-59259-694-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation